These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12880785)

  • 21. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
    Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis.
    Pelletier J; Suchet L; Witjas T; Habib M; Guttmann CR; Salamon G; Lyon-Caen O; Chérif AA
    Arch Neurol; 2001 Jan; 58(1):105-11. PubMed ID: 11176943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site and size of multiple sclerosis lesions predict enhanced or decreased female orgasmic function.
    Winder K; Seifert F; Koehn J; Deutsch M; Engelhorn T; Dörfler A; Lee DH; Linker RA; Hilz MJ
    J Neurol; 2015 Dec; 262(12):2731-8. PubMed ID: 26459094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis.
    Dineen RA; Vilisaar J; Hlinka J; Bradshaw CM; Morgan PS; Constantinescu CS; Auer DP
    Brain; 2009 Jan; 132(Pt 1):239-49. PubMed ID: 18953055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis.
    Dalton CM; Bodini B; Samson RS; Battaglini M; Fisniku LK; Thompson AJ; Ciccarelli O; Miller DH; Chard DT
    Mult Scler; 2012 Mar; 18(3):322-8. PubMed ID: 21878451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corpus callosal diffusivity predicts motor impairment in relapsing-remitting multiple sclerosis: a TBSS and tractography study.
    Kern KC; Sarcona J; Montag M; Giesser BS; Sicotte NL
    Neuroimage; 2011 Apr; 55(3):1169-77. PubMed ID: 21056674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M; Buck D; Förschler A; Boucard CC; Arsic M; Schmidt P; Gaser C; Berthele A; Hoshi M; Jochim A; Kronsbein H; Zimmer C; Hemmer B; Ilg R
    Mult Scler; 2013 Oct; 19(11):1485-92. PubMed ID: 23462349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients.
    Eftekhari E; Hojjat SP; Vitorino R; Carroll TJ; Cantrell CG; Lee L; Taylor MW; Morrow SA; Benhabib H; Aviv RI; Kassner A
    Neuroradiology; 2017 Aug; 59(8):771-780. PubMed ID: 28623483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrinsic functional plasticity of the sensorimotor network in relapsing-remitting multiple sclerosis: evidence from a centrality analysis.
    Zhuang Y; Zhou F; Gong H
    PLoS One; 2015; 10(6):e0130524. PubMed ID: 26110420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study.
    Wybrecht D; Reuter F; Pariollaud F; Zaaraoui W; Le Troter A; Rico A; Confort-Gouny S; Soulier E; Guye M; Maarouf A; Ranjeva JP; Pelletier J; Audoin B
    PLoS One; 2017; 12(11):e0184650. PubMed ID: 29149177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low degree of cortical pathology is associated with benign course of multiple sclerosis.
    Calabrese M; Favaretto A; Poretto V; Romualdi C; Rinaldi F; Mattisi I; Morra A; Perini P; Gallo P
    Mult Scler; 2013 Jun; 19(7):904-11. PubMed ID: 23069877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal cortical thinning in patients with stable relapsing-remitting multiple sclerosis: cross-sectional-based novel estimation of gray matter kinetics.
    Orbach L; Menascu S; Hoffmann C; Miron S; Achiron A
    Neuroradiology; 2018 Feb; 60(2):179-187. PubMed ID: 29285552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment.
    Megna R; Alfano B; Lanzillo R; Costabile T; Comerci M; Vacca G; Carotenuto A; Moccia M; Servillo G; Prinster A; Brescia Morra V; Quarantelli M
    J Neurol; 2019 Feb; 266(2):361-368. PubMed ID: 30498912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis.
    Giorgio A; Stromillo ML; Bartolozzi ML; Rossi F; Battaglini M; De Leucio A; Guidi L; Maritato P; Portaccio E; Sormani MP; Amato MP; De Stefano N
    Mult Scler; 2014 Feb; 20(2):214-9. PubMed ID: 23877971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical correlations of brain lesion distribution in multiple sclerosis.
    Vellinga MM; Geurts JJ; Rostrup E; Uitdehaag BM; Polman CH; Barkhof F; Vrenken H
    J Magn Reson Imaging; 2009 Apr; 29(4):768-73. PubMed ID: 19306365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MR imaging quantitation of gray matter involvement in multiple sclerosis and its correlation with disability measures and neurocognitive testing.
    Catalaa I; Fulton JC; Zhang X; Udupa JK; Kolson D; Grossman M; Wei L; McGowan JC; Polansky M; Grossman RI
    AJNR Am J Neuroradiol; 1999 Oct; 20(9):1613-8. PubMed ID: 10543630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of global and regional gray matter volume decrease in multiple sclerosis.
    Grothe M; Lotze M; Langner S; Dressel A
    J Neurol; 2016 Jun; 263(6):1137-45. PubMed ID: 27094570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normalized regional brain atrophy measurements in multiple sclerosis.
    Zivadinov R; Locatelli L; Stival B; Bratina A; Grop A; Nasuelli D; Brnabic-Razmilic O; Zorzon M
    Neuroradiology; 2003 Nov; 45(11):793-8. PubMed ID: 14551760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.